Select a Region North America

Resources Library

EVERSANA’s deep bench of oncology experts leverage their extensive industry experience to inform strategies and deliver services that pave the way to commercial success. In an effort to share expert knowledge and help manufacturers understand the complexities of commercialization for new oncology therapies, EVERSANA developed a robust library of resources.

Watch recordings from industry-leading conferences, download white papers and review recent media publications.

  • Engaging Oncology Patients and Providers in the Age of COVID and Beyond 詳細情報
  • A PARTNERSHIP Q&A WITH EVERSANA AND SHORLA PHARMA 詳細情報
  • CASE STUDY: LAUNCHING A NEW THERAPY FOR BREAST CANCER 詳細情報
  • NEXT GEN COMMERCIALIZATION MODEL FOR ONCOLOGY 詳細情報
  • ADDRESSING UNMET MEDICAL NEEDS THROUGH BOLD INNOVATION 詳細情報
  • DRIVING COMMERCIAL EXCELLENCE FOR CAR-T 詳細情報
  • Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards 詳細情報

Featured Content

Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem

As physicians, patients and caregivers tirelessly fight complex diseases, a growing number of drug manufacturers are preparing to launch new oncology therapies. These high-science therapies are entering the market at rapid rates: Presently, there are 500 active cell and gene therapy agents in clinical development, with a great momentum building for immuno-oncology treatments. The Oncology Ecosystem Is Changing, and the Cost for Commercialization Is Steep. There is no question about the incredible clinical impact these long-awaited therapies can have on patients and the industry, but launching in the oncology space is not the same as it was 20 years ago for two reasons: Commercialization stakes are high. The average cost […]

Next Gen Commercialization: Accelerating Patient Access to Life-Changing Therapies

Fifty years ago, only half of the patients diagnosed with cancer in the United States would have been alive five years later. By 2009, patient survival climbed to 70%. The problem is, in all our years working in the pharmaceutical industry and oncology, commercialization has not evolved with science. Manufacturers preparing for launch probably only see three options: sell their product to a big box pharmaceutical company, license or co-promote their product to a company with an established infrastructure, or launch internally with their own team. However, today’s unpredictable landscape, coupled with inevitable industry pressures, is forcing manufacturers to seek a more complete commercialization approach with less risk and more value. […]

Disease awareness is an essential component to successful commercialization, and our award-winning agency, EVERSANA INTOUCH, has mastered the communication complexity of oncology. Learn why they are the trusted partner for oncology manufacturers.

  • Case Study: It’s Time to #OvaryAct

    Awareness about ovarian cancer was lacking. We changed that in a big way.

    詳細情報
  • #OvaryAct GIFS Making a Difference in Patients' Lives

    Real, personal stories make connections to empower patients and caregivers.

    詳細情報
  • #OvaryAct: When the Magic Happens

    Capturing brilliance, sense of hope, energy and strength from a community.

    詳細情報
  • Telehealth's Vital Role in Oncology

    Telehealth can’t be underestimated as a new model to improve patient care.

    詳細情報
  • #EraseTheLine of Care Inequality

    Launching the world's first digital platform designed for Black women by Black women.

    詳細情報
  • #ERASETHELINE Short-Listed for Prestigious D&AD Award
    #ERASETHELINE Short-Listed for Prestigious D&AD Award

    Removing barriers to quality care with a smart and compelling campaign.

    詳細情報

お問い合わせ

Schedule a meeting today!

Contact Form

  • このフィールドは入力チェック用です。変更しないでください。